Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#2 DogBull DogBull +21.11%
#3 Siacoin Siacoin +18.72%
#4 Cash Cat Cash Cat +11.39%
#5 Seeker Seeker +10.47%
#6 Akedo Akedo +8.43%
#7 0G 0G +7.70%
#8 Story Story +5.57%
#9 The Black Bull The Black Bull +5.17%
#10 Useless Coin Useless Coin +5.06%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Classifica tra le azioni #14047
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Prezzo delle azioni
$0.88012714
Ultima sincronizzazione: 2026-08-31
Capitalizzazione di mercato
$439.58M
Variazione (1 giorno)
-4.01%
Variazione (1 anno)
1,131.97%
Paese
FR
Scambia Valerio Therapeutics S.A. (ALVIO)

Categoria

Healthcare
Rapporto P/B per Valerio Therapeutics S.A. (ALVIO)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Valerio Therapeutics S.A., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Valerio Therapeutics S.A. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH